Paxlovid Useless In High Risk Patients Younger than 65 Years (Israeli Study) - YouTube
Paxlovid Useless In High Risk Patients Younger than 65 Years (Israeli Study)
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
https://www.drbeen.com/yt-special/
Want to support this work?:
Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
PayPal: https://paypal.me/mobeensyed?locale.x=en_US
My substack: https://mobeensyedmd.substack.com/
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Aug. 29 2022
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | NEJM
https://www.nejm.org/doi/full/10.1056/NEJMoa2204919?query=featured_home
nejmoa2204919_appendix.pdf
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2204919/suppl_file/nejmoa2204919_appendix.pdf
Study: Pfizer COVID pill showed no benefit in younger adults - Los Angeles Times
https://www.latimes.com/science/story/2022-08-24/pfizer-covid-pill-showed-no-benefit-in-younger-adults-study-finds
Pfizer COVID pill provides little or no benefit in adults 40 to 65
https://www.usatoday.com/story/news/health/2022/08/24/paxlovid-pfizer-covid-pill-benefits-adults/7889907001/
Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis | Infectious Diseases | JAMA Network Open | JAMA Network
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795489